These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 28660502)

  • 1. Down-regulation of PARP1 by miR-891b sensitizes human breast cancer cells to alkylating chemotherapeutic drugs.
    Xu S; Zhao C; Jia Z; Wang X; Han Y; Yang Z
    Arch Gynecol Obstet; 2017 Sep; 296(3):543-549. PubMed ID: 28660502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-7-5p-mediated downregulation of PARP1 impacts DNA homologous recombination repair and resistance to doxorubicin in small cell lung cancer.
    Lai J; Yang H; Zhu Y; Ruan M; Huang Y; Zhang Q
    BMC Cancer; 2019 Jun; 19(1):602. PubMed ID: 31215481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-31-5p regulates chemosensitivity by preventing the nuclear location of PARP1 in hepatocellular carcinoma.
    Que KT; Zhou Y; You Y; Zhang Z; Zhao XP; Gong JP; Liu ZJ
    J Exp Clin Cancer Res; 2018 Nov; 37(1):268. PubMed ID: 30400960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-216b increases cisplatin sensitivity in ovarian cancer cells by targeting PARP1.
    Liu Y; Niu Z; Lin X; Tian Y
    Cancer Gene Ther; 2017 May; 24(5):208-214. PubMed ID: 28281524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-381 overcomes cisplatin resistance in breast cancer by targeting MDR1.
    Yi D; Xu L; Wang R; Lu X; Sang J
    Cell Biol Int; 2019 Jan; 43(1):12-21. PubMed ID: 30444043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2).
    Hu H; Li S; Cui X; Lv X; Jiao Y; Yu F; Yao H; Song E; Chen Y; Wang M; Lin L
    J Biol Chem; 2013 Apr; 288(16):10973-85. PubMed ID: 23436656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Xu K; Yagüe E
    Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Qiu Y; Yagüe E; Ji W; Liu J; Zhang J
    Cell Death Dis; 2016 Jun; 7(6):e2291. PubMed ID: 27362808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).
    Jiao X; Zhao L; Ma M; Bai X; He M; Yan Y; Wang Y; Chen Q; Zhao X; Zhou M; Cui Z; Zheng Z; Wang E; Wei M
    Breast Cancer Res Treat; 2013 Jun; 139(3):717-30. PubMed ID: 23780685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-7-5p Promotes Cisplatin Resistance of Cervical Cancer Cells and Modulation of Cellular Energy Homeostasis by Regulating the Expression of the PARP-1 and BCL2 Genes.
    Yang F; Guo L; Cao Y; Li S; Li J; Liu M
    Med Sci Monit; 2018 Sep; 24():6506-6516. PubMed ID: 30219819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of MicroRNA-124 Overexpression on Anti-Tumor Drug Sensitivity.
    Chen SM; Chou WC; Hu LY; Hsiung CN; Chu HW; Huang YL; Hsu HM; Yu JC; Shen CY
    PLoS One; 2015; 10(6):e0128472. PubMed ID: 26115122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-497 induces cell apoptosis by negatively regulating Bcl-2 protein expression at the posttranscriptional level in human breast cancer.
    Wei C; Luo Q; Sun X; Li D; Song H; Li X; Song J; Hua K; Fang L
    Int J Clin Exp Pathol; 2015; 8(7):7729-39. PubMed ID: 26339338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-151-5p, targeting chromatin remodeler SMARCA5, as a marker for the BRCAness phenotype.
    Tommasi S; Pinto R; Danza K; Pilato B; Palumbo O; Micale L; De Summa S
    Oncotarget; 2016 Dec; 7(49):80363-80372. PubMed ID: 27385001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-891b is an independent prognostic factor of pancreatic cancer by targeting Cbl-b to suppress the growth of pancreatic cancer cells.
    Dong Q; Li C; Che X; Qu J; Fan Y; Li X; Li Y; Wang Q; Liu Y; Yang X; Qu X
    Oncotarget; 2016 Dec; 7(50):82338-82353. PubMed ID: 27494897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of miRNA-452 is associated with adriamycin-resistance in breast cancer cells.
    Hu Q; Gong JP; Li J; Zhong SL; Chen WX; Zhang JY; Ma TF; Ji H; Lv MM; Zhao JH; Tang JH
    Asian Pac J Cancer Prev; 2014; 15(13):5137-42. PubMed ID: 25040964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA H19 regulates proliferation and doxorubicin resistance in MCF-7 cells by targeting PARP1.
    Wang Y; Zhou P; Li P; Yang F; Gao XQ
    Bioengineered; 2020 Dec; 11(1):536-546. PubMed ID: 32345117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1.
    Wang J; Sai K; Chen FR; Chen ZP
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):147-58. PubMed ID: 23645289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
    Cao F; Yin LX
    Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host relieves lnc-IRAK3-3-sequestered miR-891b to attenuate apoptosis in Enterovirus 71 infection.
    Liao YW; Ho BC; Chen MH; Yu SL
    Cell Microbiol; 2019 Sep; 21(9):e13043. PubMed ID: 31099182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-21 regulates N-methyl-N-nitro-N'-nitrosoguanidine-induced gastric tumorigenesis by targeting FASLG and BTG2.
    Yang Q; Xu E; Dai J; Wu J; Zhang S; Peng B; Jiang Y
    Toxicol Lett; 2014 Aug; 228(3):147-56. PubMed ID: 24821435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.